[Federal Register: December 22, 2006 (Volume 71, Number 246)]
[Notices]               
[Page 77064]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr22de06-105]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Importer of Controlled Substances Notice of Registration

    By Notice dated August 15, 2006 and published in the Federal 
Register on August 22, 2006, (71 FR 48946), Cambrex North Brunswick, 
Inc., Technology Centre of New Jersey, 661 Highway One, North 
Brunswick, New Jersey 08902, made application by renewal to the Drug 
Enforcement Administration (DEA) to be registered as an importer of 
Phenylacetone (8501), a basic class of controlled substance listed in 
schedule II.
    The company plans to import the listed controlled substance to 
manufacture amphetamine.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and Sec.  952(a) and determined that 
the registration of Cambrex North Brunswick, Inc. to import the basic 
class of controlled substance is consistent with the public interest 
and with United States obligations under international treaties, 
conventions, or protocols in effect on May 1, 1971, at this time. DEA 
has investigated Cambrex North Brunswick, Inc. to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 952(a) and Sec.  958(a), and 
in accordance with 21 CFR 1301.34, the above named company is granted 
registration as an importer of the basic class of controlled substance 
listed.

    Dated: December 14, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E6-21882 Filed 12-21-06; 8:45 am]

BILLING CODE 4410-09-P